lobbying_filings_raw: f3ee7485-eec7-49a9-bfe9-8a98391e709a
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| f3ee7485-eec7-49a9-bfe9-8a98391e709a | Q1 | 400762305 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 195053 | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) | 2020 | first_quarter | 2020-04-20T12:51:43.997000-04:00 | 80000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/f3ee7485-eec7-49a9-bfe9-8a98391e709a/", "filing_uuid": "f3ee7485-eec7-49a9-bfe9-8a98391e709a", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2020, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f3ee7485-eec7-49a9-bfe9-8a98391e709a/print/", "filing_document_content_type": "text/html", "income": "80000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Steven Irizarry", "dt_posted": "2020-04-20T12:51:43.997000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "900 G Street NW", "registrant_address_2": "Suite 301", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 400762305, "url": "https://lda.senate.gov/api/v1/registrants/400762305/", "house_registrant_id": null, "name": "ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)", "description": "Lobbying Firm", "address_1": "801 Pennsylvania Ave NW", "address_2": "Suite 1026", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "VINCENT ROBERTI", "contact_telephone": "+1 202-846-8180", "dt_updated": "2026-01-20T18:17:02.586222-05:00"}, "client": {"id": 195053, "url": "https://lda.senate.gov/api/v1/clients/195053/", "client_id": 303, "name": "BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)", "general_description": "Trade association", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2016-01-01"}, "lobbying_activities": [{"general_issue_code": "ANI", "general_issue_code_display": "Animals", "description": "Genetically engineered (GE) animals", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FUE", "general_issue_code_display": "Fuel/Gas/Oil", "description": "Biofuels, renewable chemicals/bio-based products", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66687, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": "ANDREW", "middle_name": "K.", "last_name": "COLE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Vaccines and infectious diseases; antimicrobials", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66687, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": "ANDREW", "middle_name": "K.", "last_name": "COLE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to the Coronavirus Aid, Relief, and Economic Security (CARES) Act's SBA Paycheck Protection Program\nIssued relating to the 340B Drug Pricing Program\nBiodefense research, development, and procurement issues; Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program\nIssues related to biosimilars, generally; access to samples for testing; coding; naming; interchangeability and pharmacy substitution; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act\nIssues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. \nIssues related to the importation of prescription medicines, generally", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66687, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": "ANDREW", "middle_name": "K.", "last_name": "COLE", "suffix": null, "suffix_display": null}, "covered_position": "Intern for Senator Don Nickels (R-OK)", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Funding for antimicrobial resistance programs\nFunding for renewable chemicals/bio-based products \nFunding for biodefense and emergency preparedness research, development and procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66687, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": "ANDREW", "middle_name": "K.", "last_name": "COLE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to reimbursement under Medicare Part B generally\nIssues related to Medicare Part D, generally\nHHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nValue-based contracting and communications", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56477, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEVEN", "nickname": null, "middle_name": "E", "last_name": "IRIZARRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64580, "prefix": null, "prefix_display": null, "first_name": "VINCENT", "nickname": null, "middle_name": "A.", "last_name": "ROBERTI, SR.", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66687, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": "ANDREW", "middle_name": "K.", "last_name": "COLE", "suffix": null, "suffix_display": null}, "covered_position": "Intern for Senator Don Nickels (R-OK)", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | DC | DC | US | US | Trade association | 0 | 0 | 971763 | normalized_name_state | 0.9 |